Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Techne (TECH) Operating Expenses (2016 - 2026)

Bio-Techne has reported Operating Expenses over the past 17 years, most recently at $136.8 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 6.59% year-over-year to $136.8 million; the TTM value through Dec 2025 reached $675.8 million, up 15.59%, while the annual FY2025 figure was $688.0 million, 22.2% up from the prior year.
  • Operating Expenses for Q4 2025 was $136.8 million at Bio-Techne, down from $140.5 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $222.7 million in Q2 2025 and troughed at $99.6 million in Q1 2021.
  • A 5-year average of $133.3 million and a median of $126.3 million in 2022 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: soared 45.08% in 2021 and later decreased 8.02% in 2023.
  • Year by year, Operating Expenses stood at $121.3 million in 2021, then decreased by 4.84% to $115.5 million in 2022, then grew by 20.02% to $138.6 million in 2023, then rose by 5.69% to $146.5 million in 2024, then fell by 6.59% to $136.8 million in 2025.
  • Business Quant data shows Operating Expenses for TECH at $136.8 million in Q4 2025, $140.5 million in Q3 2025, and $222.7 million in Q2 2025.